Literature DB >> 30847324

Candiduria in Hospitalized Patients and Identification of Isolated Candida Species by Morphological and Molecular Methods in Ilam, Iran.

Afagh Fazeli1, Parivash Kordbacheh1, Ali Nazari2, Roshanak Daie Ghazvini1, Hossein Mirhendi1, Mahin Safara1, Heidar Bakhshi1, Razieh Yaghoubi1.   

Abstract

BACKGROUND: Candiduria in hospitalized patients may represent contamination, colonization, or urinary tract infections. On the other hand, candidemia and upper urinary tract infection could be the complications of candiduria. The aim of this study was to determine candiduria in hospitalized patients and identify isolated Candida species by conventional and molecular methods.
METHODS: This cross-sectional study was conducted on hospitalized patients in Imam Khomeini and Mostafa Khomeini hospitals in Ilam, western Iran from Jan to Dec 2016. Urine samples of hospitalized patients were collected during a period of 4 months for diagnosis of candiduria. Primary identification was done by conventional methods. PCR profile was carried out using phenol-chloroform method and confirmed using restriction fragment length polymorphism (PCR-RFLP) technique by MspI restriction enzyme.
RESULTS: Candiduria was diagnosed in 18 (9.2%) cases from a total of 195 patients. Isolated yeasts were identified as C. albicans (n: 13), C. glabrata (n: 5), and C. parapsilosis (n: 1) in the one case both C. albicans and C. glabrata were isolated from a urine sample.
CONCLUSION: Candida urinary tract infection is becoming increasingly common in hospitalized patients but, differentiation fungal colonization from infection and identification of etiologic agents for optimal treatment is necessary.

Entities:  

Keywords:  Candida albicans; Candida spp.; Candiduria; Hospitalized patients; Yeast

Year:  2019        PMID: 30847324      PMCID: PMC6401579     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Since the hospitalized patients are usually associated with treatment by broad-spectrum antimicrobial agents, corticosteroids, immunosuppressive and cytotoxic drugs, urinary tract fungal infection is remarkably increased in them. On the other hand, there are many other risk factors among the patients which are including old age, diabetes mellitus, chronic renal failure, dialysis, renal transplantation, and malformation of urinary tract (1). The presence of Candida in urine may be due to colonization of the yeast in perineum or urinary catheter or may be related to invasive infections such as pyelonephritis/cystitis or disseminated candidiasis (2). In healthy people Candida species are unusual reason for urinary tract infections (UTIs) but, this fungal infection is more common in hospitalized patients. The urinary tract may be invaded either by bloodstream or retrograde via the urethra and bladder. Candida species virulence factors such as phenotypic switching, dimorphism, and hydrolytic enzymes have essential role in colonization and invasion of urinary tract system. Therefore, the presence of yeast in the urine could be indicative of invasive urinary tract infection especially in critically ill patients (3). In spite of several studies, the true incidence of candiduria and response to treatment is not well defined. The resistance of Candida spp. especially non-albicans Candida (NAC) spp. to antifungal drugs also should be considered. Although C. albicans is the most common (50%–65%) etiologic agent of candiduria, the prevalence of infections caused by NAC spp. has increased in recent years (4, 5). The aim of this study was to determine the frequency of candiduria in hospitalized patients and identify isolated candida species by conventional and molecular methods in order to early diagnosis of invasive fungal infections in these patients.

Materials and Methods

This cross-sectional study was conducted on hospitalized patients in Imam Khomeini and Mostafa Khomeini hospitals in Ilam, western Iran from Jan to Dec 2016. Informed consent to participate in this study was signed by patients, after that the study was approved by the Ethics Committee of Tehran University of Medical Sciences. Urine samples were obtained in sterile urine bottles. Totally, 10 μl of the urine sample was cultured on CHROM agar candida medium (CHROM agar candida, France) before and after centrifugation. The culture media were incubated at 35 °C for 48 h and evaluated based on color and number of growth colonies. If no growth was seen the media were incubated for several more days. Isolated colonies also were cultured on corn meal agar medium (Micromedia, Hungary) supplemented with Tween 80 for identification of Candida species based on their morphology. In this study urine, wet-mount examination was done to detect fungal elements in the urine sediment. PCR-RFLP method was performed for definite identification of species. All isolated strains subcultured on Sabouraud Dextrose Agar medium (Sigma, USA) and genomic DNA were extracted using the phenol-chloroform method. PCR amplification was performed using the universal primers ITS1 (forward: 5′ -TCC- GTA- GGT- GAA -CCT –GCG- G-3′) and ITS4 (reverse: 5′ TCC- TCC- GCT- TAT- TGA -TAT -GC-3′). PCR products were digested by MspI restriction enzyme and restriction fragments were separated by 2% agarose gel electrophoresis (6). Demographic data were analyzed using Chi-Square test by SPSS version 22 (Chicago, IL, USA) ver. 15 and a P<0.05 was considered statistically significant.

Results

Overall, 195 patients who included 80 (41.02%) males and 115 (58.97%) females aged 14–93 yr (median age 53 yr) were enrolled. None of the patients received antifungal drugs for prophylaxis or treatment. Underlying conditions in understudy patients were include: diabetes mellitus, antibiotic therapy, indwelling urinary catheters and blood pressure. The urine cultures of 18 (9.7%) patients were yielded Candida species and colony count was different from 2000 to >105 cfu/ml (Table 1). By morphological methods, some of isolates were identified as pure, including C. albicans with light green colonies (n: 13), (Fig. 1), C. glabrata with purple to pink colonies (n: 5), (Fig. 2) and C. parapsilosis with pink-cream colonies (n: 1), (Fig. 3). In urine culture of a 28 yr old female hospitalized in ICU, both colonies of C. albicans and C. glabrata were growth as mixed (Fig. 4). Direct examination showed fungal elements in the sediment of urine samples in 17 patients with candiduria and budding yeast cells, pseudohyphae, and true mycelium were detected (Figs. 5, 6).
Table 1:

The comparison of morphological and molecular methods in diagnosis of candiduria in hospitalized patients in Imam Khomeini and Mostafa Khomeini hospitals in Ilam, western Iran

NO.Direct SmearColony count in urine(before centrifugation)Colony count in 1ml urine sediment(after centrifugation)Culture on CHOROM agar CANDIDAPCR-RFLP
1Budding yeast cells, pseudo hyphae C. albicans with green light colonies C. albicans
2Budding yeast cells, pseudo hyphae8000>10 5 10000>10 5 C. albicans
3Budding yeast cells, pseudo hyphae and true mycelium10000130000 C. albicans
4Budding yeast cells, pseudo hyphae700012000 C. albicans
5Budding yeast cells, pseudo hyphae C. albicans with green light & C.glabrata with purple to pink colonies C. albicans and C.glabrata
6_>10 5 1000>10 5 2000 C. albicans with green light colonies C. albicans
7Budding yeast cells, pseudo hyphae, true mycelium800010000 C. albicans
8Budding yeast cells>10 5 >10 5 C. albicans
9Budding yeast cells30005000 C. albicans
10Budding yeast cells>10 5 >10 5 C. albicans
11Budding yeast cells50007000 C.glabrata with purple to pink colonies C.glabrata
12Budding yeast cells60006000 C.glabrata
13Budding yeast cells400010000 C.glabrata
14Budding yeast cells, pseudo hyphae>10 5 >10 5 C. albicans with green light colonies C. albicans
15Budding yeast cells, pseudo hyphae50008000 C. albicans
16Budding yeast cells, pseudo hyphae50005000 C. albicans with green light colonies C. albicans
17Budding yeast cells, pseudo hyphae>10 5 >10 5 C.parapsilosis with pink-cream colonies C.parapsilosis
18Budding yeast cells40005000 C.glabrata with purple to pink colonies C.glabrata
Fig. 1:

Candida albicans isolated from urine culture on CHROMagar candida incubated at 35 °C for 48 h

Fig. 2:

Candida glabrata isolated from urine culture on CHROM agar candida incubated at 35 °C for 48

Fig. 3:

Candida parapsilosis isolated from urine culture onCHROM agar candida incubated at 35 °C for 48

Fig. 4:

Candida glabrata and C. albicans isolated together from urine culture on CHROM agar candida incubated at 35 °C for 48

Fig. 5:

Budding yeast cells, pseudohyphae and true mycelium in direct examination of urine sediment (×400)

Fig. 6:

Patterns of PCR-RFLP products of Candida spp. isolated from candiduria after digestion by the restriction enzyme MspI. Lanes of 1,2,3,4,7,8,9,13,14 represent C. albicans (238, 297 bp); 5,6,10,11,12 C. glabrata (557, 314 bp) and 15 C. parapsilosis (520 bp). Lane M is 100 bp ladder molecular size marker

The comparison of morphological and molecular methods in diagnosis of candiduria in hospitalized patients in Imam Khomeini and Mostafa Khomeini hospitals in Ilam, western Iran Candida albicans isolated from urine culture on CHROMagar candida incubated at 35 °C for 48 h Candida glabrata isolated from urine culture on CHROM agar candida incubated at 35 °C for 48 Candida parapsilosis isolated from urine culture onCHROM agar candida incubated at 35 °C for 48 Candida glabrata and C. albicans isolated together from urine culture on CHROM agar candida incubated at 35 °C for 48 Budding yeast cells, pseudohyphae and true mycelium in direct examination of urine sediment (×400) Patterns of PCR-RFLP products of Candida spp. isolated from candiduria after digestion by the restriction enzyme MspI. Lanes of 1,2,3,4,7,8,9,13,14 represent C. albicans (238, 297 bp); 5,6,10,11,12 C. glabrata (557, 314 bp) and 15 C. parapsilosis (520 bp). Lane M is 100 bp ladder molecular size marker Using PCR-RFLP method, 19 isolated yeasts were identified as C. cabicans (n: 13), C. glabrata (n: 5), and C. parapsilosis (n: 1), respectively (Fig. 6). Molecular findings confirmed the result of morphological method (Table 1). C. albicans was the most common Candida species (68.42%) isolated from the urine samples followed by C. glabrata (26.31%), and C. parapsilosis (5.26%). Overall, 18 cases of candiduria were identified in 7 (8.75%) male and 11(9.6%) female. However, there was not statistically correlation between sex and candiduria (P<0.42). None of the women had vulvovaginal candidiasis. In this study significant correlation between diabetes mellitus, antibiotic therapy and indwelling urinary catheters with candiduria was observed (P<0.05).

Discussion

The frequency of UTIs caused by Candida spp. has been increased especially in hospitalized patients. Individuals with UTI and underlying diseases should be treated with appropriate antifungal drugs. However, there is no suitable protocol for management of candiduria and differentiation of colonization from UTI is usually difficult. Therefore, treatment of candiduria depends on the patient’s clinical condition (6–8). In present study, candiduria was observed in 9.2% of patients hospitalized in different wards of two teaching hospitals in Ilam. This rate is compatible with some other studies (9–13). Besides, different from low rate of candiduria was reported in hospitalized patients in Hashemi Nejad hospital in Tehran (14). It may be related to different population of patients and differences in hospital setting. Although candiduria is more common in women and usually associated with vaginal candidiasis (15, 16), in our study none of patients had vaginal Candida infection and there was no significant correlation between gender and candiduria. Absence of vaginal candidiasis could be an important factor in this situation. Candiduria is usually associated with diabetes mellitus, indwelling urinary catheter and treatment with antibacterial drugs (17–19). Our study also showed significant correlation (P<0.05) between candiduria with above mentioned predisposing factors and emphasizes special attention for Candida UTIs in these high-risk patients. Because of relatively large amount of lipids in cell wall of some Candida species, yeast cells may be float in urine (20) thus urine samples were cultured before and after centrifugation but, numbers of colonies yielded from urine sediments were much greater than those yielded from whole urine specimens. This finding implies to importance of using urine sediment to isolate Candida species from urine samples. In the present study, C. albicans was the most common (68.42%) isolated species from urine samples followed by C. glabrata (26.31%) and C. parapsilosis (5.26%). This result is in agreement with the most conducted studies in Iran (9, 10, 14). However, in contrast with some others that showed NAC species was more commonly isolated from the urine samples (11, 21). This could be related to different populations of patients, and also in different geographic regions. In the present study, we use mycological and molecular (PCR-RFLP) methods to identify Candida species and in both, the same results were obtained. This finding implies to importance of conventional method in diagnosis of fungal diseases. In direct examination of urine sediments budding yeast cell, pseudohyphae and true mycelium were seen in 17 patients with candiduria. This finding implies to importance and necessity of direct urine examination in diagnosis of candiduria. There is not standard colony counting for differentiation of UTI from urine contamination and in our study colony count was different from 4000 to >105 CFU/ml in positive culture from urine samples. However, these findings need more evaluation and follow up patients especially those with serious predisposing factors and long hospital stay.

Conclusion

Candiduria in hospitalized patients may represent urinary tract infection and requires early diagnosis and treatment. It is difficult to differentiate urinary infection from colonization and treatment should be considered in related to patient’s condition. In present study, C. albicans was the most common isolated species but drug-resistant NAC species also should be considered. Obviously, definitive diagnosis of Candida UTI needs using new laboratory and molecular methods.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  15 in total

1.  Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization.

Authors:  N Febré; V Silva; E A Medeiros; S B Wey; A L Colombo; O Fischman
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 2.  Invasive fungal infections in renal transplant recipients.

Authors:  Parisa Badiee; Abdolvahab Alborzi
Journal:  Exp Clin Transplant       Date:  2011-12       Impact factor: 0.945

3.  Candida urinary tract infection: pathogenesis.

Authors:  John F Fisher; Kevin Kavanagh; Jack D Sobel; Carol A Kauffman; Cheryl A Newman
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication.

Authors:  J Delgado; N Calvo; A Gomis; I Pérez-Flores; A Rodríguez; N Ridao; R Valero; A I Sánchez-Fructuoso
Journal:  Transplant Proc       Date:  2010-10       Impact factor: 1.066

5.  Urinary tract infections in solid organ transplant recipients.

Authors:  J C Rice; N Safdar
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

6.  Fungal urinary tract infections in patients at risk.

Authors:  S Krcmery; M Dubrava; V Krcmery
Journal:  Int J Antimicrob Agents       Date:  1999-05       Impact factor: 5.283

Review 7.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

8.  Predictors and outcomes of candiduria in renal transplant recipients.

Authors:  N Safdar; W R Slattery; V Knasinski; R E Gangnon; Zhanhai Li; J D Pirsch; D Andes
Journal:  Clin Infect Dis       Date:  2005-04-12       Impact factor: 9.079

Review 9.  Nosocomial candiduria: a review.

Authors:  T Lundstrom; J Sobel
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

Review 10.  Candiduria: a review of clinical significance and management.

Authors:  Zakeya Abdulbaqi Bukhary
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-05
View more
  6 in total

1.  Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles.

Authors:  Narges Aslani; Roya Kokabi; Fatemeh Moradi; Kiana Abbasi; Narges Vaseghi; Mohammad Hosein Afsarian
Journal:  Curr Med Mycol       Date:  2021-12

2.  Polymicrobial Biofilm Dynamics of Multidrug-Resistant Candida albicans and Ampicillin-Resistant Escherichia coli and Antimicrobial Inhibition by Aqueous Garlic Extract.

Authors:  Priya Ashrit; Bindu Sadanandan; Kalidas Shetty; Vijayalakshmi Vaniyamparambath
Journal:  Antibiotics (Basel)       Date:  2022-04-25

3.  High prevalence of asymptomatic nosocomial candiduria due to Candida glabrata among hospitalized patients with heart failure: a matter of some concern?

Authors:  Seyed Reza Aghili; Mahdi Abastabar; Ameneh Soleimani; Iman Haghani; Soheil Azizi
Journal:  Curr Med Mycol       Date:  2020-12

4.  Identification of Candida Species from Clinical Samples in a Honduran Tertiary Hospital.

Authors:  Kathy Montes; Bryan Ortiz; Celeste Galindo; Isis Figueroa; Sharleen Braham; Gustavo Fontecha
Journal:  Pathogens       Date:  2019-11-15

Review 5.  Candida auris Urinary Tract Infections and Possible Treatment.

Authors:  Nicole Griffith; Larry Danziger
Journal:  Antibiotics (Basel)       Date:  2020-12-12

Review 6.  Urine Sediment Findings and the Immune Response to Pathologies in Fungal Urinary Tract Infections Caused by Candida spp.

Authors:  José Antonio Tesser Poloni; Liane Nanci Rotta
Journal:  J Fungi (Basel)       Date:  2020-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.